The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Relmada Therapeutics Inc shares valued at $113,300 were purchased by TRAVERSA SERGIO on Dec 15 ’25. At $4.12 per share, TRAVERSA SERGIO acquired 27,500 shares. The insider’s holdings grew to 1,300,000 shares worth approximately $6.28 million following the completion of this transaction.
Also, Shenouda Maged purchased 11,665 shares, netting a total of over 48,060 in proceeds. Following the buying of shares at $4.12 each, the insider now holds 800,000 shares.
Before that, Shenouda Maged had added 500,000 shares to its account. In a trade valued at $1,100,000, the Chief Financial Officer bought Relmada Therapeutics Inc shares for $2.20 each. Upon closing the transaction, the insider’s holdings increased to 500,000 shares, worth approximately $3.81 million.
As published in their initiating research note from Jefferies on December 22, 2025, Relmada Therapeutics Inc [RLMD] has been a Buy and the price target has been revised to $69. Analysts at Mizuho upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in mid November. As of December 05, 2024, Mizuho has decreased its “an Outperform” rating to a “Neutral” for RLMD. Earlier on September 17, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for RLMD stock which previously was a “a Hold”.
Analyzing RLMD Stock Performance
On last trading session, Relmada Therapeutics Inc [NASDAQ: RLMD] rose 6.62% to $4.83. The stock’s lowest price that day was $4.44, but it reached a high of $4.84 in the same session. During the last five days, there has been a surge of approximately 7.57%. Over the course of the year, Relmada Therapeutics Inc shares have jumped approximately 1161.10%. Shares of the company reached a 52-week high of $5.12 on 11/19/25 and a 52-week low of $0.24 on 03/03/25.
Support And Resistance Levels for Relmada Therapeutics Inc (RLMD)
According to the 24-hour chart, there is a support level at 4.57, which, if violated, would cause prices to drop to 4.30. In the upper region, resistance lies at 4.97. The next price resistance is at 5.10. RSI (Relative Strength Index) is 65.29 on the 14-day chart, showing neutral technical sentiment.
Is Relmada Therapeutics Inc subject to short interest?
Stocks of Relmada Therapeutics Inc saw a sharp rise in short interest on 2025-12-15 jumping by 34225.0 shares to 0.98 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 0.95 million shares. A jump of 3.49% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.92 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.92.
Which companies own the most shares of Relmada Therapeutics Inc (RLMD)?
In terms of Relmada Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 9 in the next 12 months, up nearly 98.68% from the previous closing price of $4.53. Analysts anticipate Relmada Therapeutics Inc stock to reach 9 by 2026, with the lowest price target being 9. In spite of this, 1 analysts ranked Relmada Therapeutics Inc stock as Sell at the end of 2026. On June 05, 2024, Goldman assigned a price target of “a Sell” to the stock and downgraded coverage with a $2.
